ESDO cooperates with national digestive oncology associations and other local or European groups in the field of digestive oncology to stimulate high-quality scientific exchange and multidisciplinary education. Our portfolio comprises different types of cooperation:

ESDO Labelled Meetings

Labelled Meetings are educational meetings organised by other associations or groups. After the evaluation by the ESDO Governing Board that the proposed program is of a high academic standard, ESDO grants the ESDO Label and promotes the event. Do you want to apply for the ESDO Label for your meeting? Click here to download the application form. Completed applications must be submitted to ESDO at least 3 months prior to the event.

ESDO Supported Meetings

Supported Meetings are educational meetings proposed, organised and financed by a third party. After the evaluation by the ESDO Governing Board that the proposed programme is of a high academic standard, ESDO can grant the event support and promotion and send a maximum of 2-3 speakers from ESDO. The multidisciplinary ESDO Lecturer Pool comprises excellent and internationally renowned experts in the field of GI Cancer. Do you want to apply for ESDO Meeting Support? Click here to download the application form. Completed applications must be submitted to ESDO at least 6 months prior to the event.

ESDO Partnership Meetings

Partnership Meetings are contractual joint venture events between ESDO and other associations or groups that promote high quality education in the field of digestive oncology. ESDO has to  be represented in the Scientific Committee and in the faculty. Please contact the ESDO Office for more information. 

ESDO Meetings

ESDO Meetings organised by ESDO office focus on high quality education in the field of digestive oncology. ESDO is entirely responsible for the programme. Please contact the ESDO Office for sponsorships and more information. 

UEG Online Education

Virtual Meetings and online courses organised by UEG - United European Gastroenterology and their partners, covering the majority of topics from the interdisciplinary fields of Gastroenterology. UEG is responsible for the programme.

Upcoming Educational Meetings

ONCODIR

Research, ESDO Partnership Meeting

Evidence-based Participatory Decision Making for Colorectal Cancer Prevention

Details

ONCODIR is developing a platform based on artificial intelligence and privacy principles. It will provide recommendation services based on input from citizens, clinicians and policy-makers. We will consider factors such as lifestyle, nutrition and economics. To validate the ONCODIR results, we will conduct laboratory tests and pilots in five EU countries that will involve medical scientists, healthcare providers, foundations and consortium experts and will consider cost-effectiveness, affordability and cost-benefit parameters. The ONCODIR consortium consists of partners from diverse technological and scientific domains with a strong research capacity. ONCODIR is part of the Cancer Mission cluster of projects focused on prevention and early detection.”

ESDO is proud to be a partner of this programme.

Look for details on the ONCODIR website

 

 

 

ONCOSCREEN

Research, ESDO Partnership Meeting

A European “Shield” against Colorectal Cancer

Details

ONCOSCREEN project plans to develop a ground-breaking set of technologies and methods for colorectal cancer screening and to improve its early detection. In close cooperation with other Mission Cancer projects, ONCOSCREEN will provide solutions for risk-stratified cancer screening programmes for citizens, an integrated diagnostic decision support tool for clinicians as well as intelligent monitoring tools for policy makers. The project will collaborate closely with national cancer mission hubs to facilitate policy dialogue on cancer and related research actions.

ESDO is proud to be a partner of this programme.

Look for details on the ONCOSCREEN website

 

 

 

Publication Snapshot on the LEVIATHAN study with Dr David Pinato

ESDO Labelled Meeting

Expert insights on 2nd line treatment selection post atezolizumab + bevacizumab for HCC

Details

ESDO is pleased to endorse this publication snapshot of Dr. David Pinato summarising the main results and conclusions from the LEVIATHAN study, placing the results into clinical context and how these fit into the evolving treatment landscape for patients with advanced HCC.

to watch the video please visit the website 

 

 

2nd ESDO Webinar 29 January 2026 at 18:00 CET

ESDO Meeting, ESDO Partnership Meeting

New data on GI cancer from ASCO GI 2026

Details

save the date for our next ESDO GI WEBINAR summarising ASCO GI_2026

Live Webinar: Thursday 29 January 2026 / 18:00 - 19:30

Don't miss this ESDO educational session with international experts discuss practice-changing data in GI oncology. Gain first-hand insights and engage with thought leaders in the field

Registration and all details on this website

 

 

Contact

phone: +43 (0) 1 405 13 83 - 38
e-mail:  info@remove-this.esdo.eu

@ESDO_tweets   LinkedIn   youtube

All rights reserved

Use of this website constitutes acceptance of the User Agreement, the General Terms and Conditions and the Data Protection Statement.

Copyright

© ESDO 2025
Design and Development by

Koerbler